Modem concepts of primary thyroid gland failure

Clinical Chemistry

Volumn 42, Issue 1, 1996, Pages 179-182

  Ridgway, E Chester ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Hormone therapy; Hypothyroidism; Myxedema; Thyrotropin; Thyroxine

Indexed keywords

THYROID HORMONE; THYROTROPIN;

CONFERENCE PAPER; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LABORATORY DIAGNOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; SEX DIFFERENCE; THYROTROPIN BLOOD LEVEL;

HUMANS; HYPOTHYROIDISM; THYROID HORMONES;

EID: 0030032838     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.1.179     Document Type: Article

References (15)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark E, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93.
2. Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA 1989;261:2653-5.
3. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
4. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab 1990;70:453-60.
5. Beck-Peccoz P, Amr S, Menezes-Ferreria NM, Faglia G, Weintraub BD. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin releasing hormone. N Engl J Med 1985;312:1085-90.
6. McDermott MT, Ridgway EC. Thyroid hormone resistance syndromes. Am J Med 1993;94:424-32.
7. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-7.
8. Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990;88:638-71.
9. Zwillich CW, Pierson DJ, Hofeldt FD, Lufkin EG, Weil JV. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975;292: 662-5.
10. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987;316:764-70.
11. Hennessey JV, Evaul JE, Tseng YC, Burman KD, Wartofsky L. L-Thyroxine dosage, a reevaluation of therapy with contemporary preparations. Ann Intern Med 1986;105:11-5.
12. Rosenbaum RL, Barzel US. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982;96:53-5.
13. Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983;75:206-9.
14. Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann Intern Med 1972;77:549-55.
15. Ladenson PW, Goldenheim PD, Ridgway EC. Rapid pituitary and peripheral tissue responses to intravenous L-triiodothyronine in hypothyroidism. J Clin Endocrinol Metab 1983;56:1252-9